glp-1 microdosing for menopause GLP-1s: A Doctor's Guide to Gentle, Effective Metabolic Reset: Shamsah Amersi, MD: OB-GYNs Jill - More and more

Both drugs led to an elevation in pancreatic enzymes

After reading the first section you should already understand why, but lets recap it here

Contrave: Nausea, constipation, headache, insomnia Increased blood pressure and heart rate Other effects: anxiety, dizziness, dry mouth, tremors, risk of seizures in susceptible individuals Serious risks: liver problems, severe allergic reactions, neuropsychiatric events, including mood changes or suicidal thoughts Wegovy: Gastrointestinal issues: nausea, vomiting, diarrhea, constipation, abdominal pain Other effects: fatigue, headache, dizziness (especially during dose escalation) Serious risks: pancreatitis, gallbladder disease, thyroid tumors in high-risk patients, increased heart rate Important: Neither medication is a cure for obesity

Fasted blood glucose decreased from 97 to 81 mg dL 1 , with hemoglobin A1C remaining consistent at 4.8%4.9%

This monitoring schedule should be maintained for patients starting semaglutide

Earlier this month, Lilly and GSK both announced plans for new US facilities